Inoviq Ltd has released a press release.
Appendix 4C & Quarterly Activities Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Inoviq
- AGM Presentation
- BARD1 Appoints New CSO
- BARD1 Share Purchase Plan Completed Oversubscribed
- Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test
- BARD1 lodges spp and options prospectus
Later from Inoviq
- Brazilian Patent Issued for Lung & Colorectal Cancer
- Update on Legal Proceedings and BARD1 Autoantibody Program
- INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
- INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests
- IIQ Appendix 4C & Quarterly Activities Report - March 2022
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq